Resatorvid alleviates experimental inflammatory TMJOA by restraining chondrocyte pyroptosis and synovial inflammation

Abstract Objectives Innate immunity plays a significant role in the pathogenesis of temporomandibular joint osteoarthritis (TMJOA), which is characterized by synovial inflammation and condylar cartilage degradation. We are urged to investigate the impact of Resatorvid, a preventative drug that inhib...

Full description

Bibliographic Details
Main Authors: Xin Liu, Huimin Li, Yaping Feng, Huilin Guo, Yingjie Li, Jin Ke, Xing Long
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Arthritis Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13075-023-03214-4
_version_ 1797414369124941824
author Xin Liu
Huimin Li
Yaping Feng
Huilin Guo
Yingjie Li
Jin Ke
Xing Long
author_facet Xin Liu
Huimin Li
Yaping Feng
Huilin Guo
Yingjie Li
Jin Ke
Xing Long
author_sort Xin Liu
collection DOAJ
description Abstract Objectives Innate immunity plays a significant role in the pathogenesis of temporomandibular joint osteoarthritis (TMJOA), which is characterized by synovial inflammation and condylar cartilage degradation. We are urged to investigate the impact of Resatorvid, a preventative drug that inhibits Toll-like receptor 4 (TLR4), on experimental inflammatory TMJOA pathology. Methods An intra-articular injection of complete Freund’s adjuvant (CFA) was used to induce an experimental inflammatory mouse TMJOA model, and TLR4 expression was identified by immunofluorescent labeling. Intraperitoneal injections of Resatorvid were administered to CFA-induced TMJOA mice, and the pathology of TMJOA animals with and without Resatorvid treatment was examined by H&E, Safranin-O/Fast Green, and TRAP staining, as well as micro-CT, immunohistochemistry, and immunofluorescence. The impact of Resatorvid on chondrocyte pyroptosis and macrophage inflammation was further investigated using ATDC5 chondrocytes and RAW264.7 macrophages pretreated with relevant antagonists. Results CFA-induced TMJOA mice revealed remarkable synovial inflammation, together with a time course of cartilage degradation and bone destruction, with TLR4 elevated in the synovium and condylar cartilage. Prophylactic treatment with Resatorvid mitigated synovial inflammation, cartilage degeneration, and bone destruction in CFA-induced TMJOA mice and downregulated MyD88/NF-κB expression. Ex vivo studies demonstrated that Resatorvid treatment alleviated NOD-like receptor protein 3 (NLRP3)-mediated chondrocyte pyroptosis and degeneration and relieved macrophage inflammation by preventing reactive oxygen species (ROS) production through NLRP3 signaling. Conclusion Prophylactic treatment with Resatorvid alleviates TMJOA pathology by inhibiting chondrocyte pyroptosis and degeneration, as well as ROS-induced macrophage inflammation, through TLR4/MyD88/NF-κB/NLRP3.
first_indexed 2024-03-09T05:32:05Z
format Article
id doaj.art-305785a3f9134636b738df8e81034e2b
institution Directory Open Access Journal
issn 1478-6362
language English
last_indexed 2024-03-09T05:32:05Z
publishDate 2023-11-01
publisher BMC
record_format Article
series Arthritis Research & Therapy
spelling doaj.art-305785a3f9134636b738df8e81034e2b2023-12-03T12:31:50ZengBMCArthritis Research & Therapy1478-63622023-11-0125111410.1186/s13075-023-03214-4Resatorvid alleviates experimental inflammatory TMJOA by restraining chondrocyte pyroptosis and synovial inflammationXin Liu0Huimin Li1Yaping Feng2Huilin Guo3Yingjie Li4Jin Ke5Xing Long6State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan UniversityState Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan UniversityState Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan UniversityState Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan UniversityState Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan UniversityState Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan UniversityState Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan UniversityAbstract Objectives Innate immunity plays a significant role in the pathogenesis of temporomandibular joint osteoarthritis (TMJOA), which is characterized by synovial inflammation and condylar cartilage degradation. We are urged to investigate the impact of Resatorvid, a preventative drug that inhibits Toll-like receptor 4 (TLR4), on experimental inflammatory TMJOA pathology. Methods An intra-articular injection of complete Freund’s adjuvant (CFA) was used to induce an experimental inflammatory mouse TMJOA model, and TLR4 expression was identified by immunofluorescent labeling. Intraperitoneal injections of Resatorvid were administered to CFA-induced TMJOA mice, and the pathology of TMJOA animals with and without Resatorvid treatment was examined by H&E, Safranin-O/Fast Green, and TRAP staining, as well as micro-CT, immunohistochemistry, and immunofluorescence. The impact of Resatorvid on chondrocyte pyroptosis and macrophage inflammation was further investigated using ATDC5 chondrocytes and RAW264.7 macrophages pretreated with relevant antagonists. Results CFA-induced TMJOA mice revealed remarkable synovial inflammation, together with a time course of cartilage degradation and bone destruction, with TLR4 elevated in the synovium and condylar cartilage. Prophylactic treatment with Resatorvid mitigated synovial inflammation, cartilage degeneration, and bone destruction in CFA-induced TMJOA mice and downregulated MyD88/NF-κB expression. Ex vivo studies demonstrated that Resatorvid treatment alleviated NOD-like receptor protein 3 (NLRP3)-mediated chondrocyte pyroptosis and degeneration and relieved macrophage inflammation by preventing reactive oxygen species (ROS) production through NLRP3 signaling. Conclusion Prophylactic treatment with Resatorvid alleviates TMJOA pathology by inhibiting chondrocyte pyroptosis and degeneration, as well as ROS-induced macrophage inflammation, through TLR4/MyD88/NF-κB/NLRP3.https://doi.org/10.1186/s13075-023-03214-4TMJOAResatorvidChondrocyte pyroptosisMacrophage inflammationNLRP3ROS
spellingShingle Xin Liu
Huimin Li
Yaping Feng
Huilin Guo
Yingjie Li
Jin Ke
Xing Long
Resatorvid alleviates experimental inflammatory TMJOA by restraining chondrocyte pyroptosis and synovial inflammation
Arthritis Research & Therapy
TMJOA
Resatorvid
Chondrocyte pyroptosis
Macrophage inflammation
NLRP3
ROS
title Resatorvid alleviates experimental inflammatory TMJOA by restraining chondrocyte pyroptosis and synovial inflammation
title_full Resatorvid alleviates experimental inflammatory TMJOA by restraining chondrocyte pyroptosis and synovial inflammation
title_fullStr Resatorvid alleviates experimental inflammatory TMJOA by restraining chondrocyte pyroptosis and synovial inflammation
title_full_unstemmed Resatorvid alleviates experimental inflammatory TMJOA by restraining chondrocyte pyroptosis and synovial inflammation
title_short Resatorvid alleviates experimental inflammatory TMJOA by restraining chondrocyte pyroptosis and synovial inflammation
title_sort resatorvid alleviates experimental inflammatory tmjoa by restraining chondrocyte pyroptosis and synovial inflammation
topic TMJOA
Resatorvid
Chondrocyte pyroptosis
Macrophage inflammation
NLRP3
ROS
url https://doi.org/10.1186/s13075-023-03214-4
work_keys_str_mv AT xinliu resatorvidalleviatesexperimentalinflammatorytmjoabyrestrainingchondrocytepyroptosisandsynovialinflammation
AT huiminli resatorvidalleviatesexperimentalinflammatorytmjoabyrestrainingchondrocytepyroptosisandsynovialinflammation
AT yapingfeng resatorvidalleviatesexperimentalinflammatorytmjoabyrestrainingchondrocytepyroptosisandsynovialinflammation
AT huilinguo resatorvidalleviatesexperimentalinflammatorytmjoabyrestrainingchondrocytepyroptosisandsynovialinflammation
AT yingjieli resatorvidalleviatesexperimentalinflammatorytmjoabyrestrainingchondrocytepyroptosisandsynovialinflammation
AT jinke resatorvidalleviatesexperimentalinflammatorytmjoabyrestrainingchondrocytepyroptosisandsynovialinflammation
AT xinglong resatorvidalleviatesexperimentalinflammatorytmjoabyrestrainingchondrocytepyroptosisandsynovialinflammation